Enavate Sciences GP, LLC
- SEC CIK
- 0001953107
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 7
- 0 vs. Q1 2026
- Portfolio value
- $345.4M
- −$6.13M (−1.7%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SIONSionna Therapeutics, Inc. | COM | 2,478,030 | $109.0M | 31.6% | 00.0% | Unchanged | History |
| ZBIOZenas BioPharma, Inc. | COM | 3,919,159 | $99.5M | 28.8% | 00.0% | Unchanged | History |
| IMNMImmunome Inc. | COM | 3,613,799 | $76.6M | 22.2% | 00.0% | Unchanged | History |
| BBOTBridgeBio Oncology Therapeutics, Inc. | COM NEW | 2,626,946 | $20.0M | 5.8% | 00.0% | Unchanged | History |
| CMPXCompass Therapeutics, Inc. | COM | 7,788,150 | $17.1M | 4.9% | 00.0% | Unchanged | History |
| UPBUpstream Bio, Inc. | COM | 2,459,703 | $17.0M | 4.9% | 00.0% | Unchanged | History |
| CAMPCamp4 Therapeutics Corp | COM | 1,425,541 | $6.23M | 1.8% | −765,379−34.9% | Reduced | History |